Bacopa Monnieri for Acute cognition and Bacopa Monnieri
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
Bacopa Monnieri for Acute cognition
Evidence grade D — No same-day effect
Grade D1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
Bacopa Monnieri
The nootropic that actually improves memory — but slowly, over 8–12 weeks, not on the day you take it.
Grade B2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Bacopa Monnieri for Acute cognition | Bacopa Monnieri |
|---|---|---|
| Acute cognition | Evidence grade DTrivial effecthighNo same-day effect | Evidence grade DTrivial effecthighNo same-day effect |
Graded only in Bacopa Monnieri for Acute cognition
None — every outcome it grades is graded in both.
Graded only in Bacopa Monnieri
- Memory (chronic) Small effectEvidence grade B
What each entry says about the other
- Bacopa Monnieri for Acute cognition’s entry · Goes with: Read the full Bacopa Monnieri monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.